AAAAAA

   
Results: 1-15 |
Results: 15
Local high-capacity adenovirus-mediated mCTLA4lg and mCD40lg expression prolongs recombinant gene expression in skeletal muscle
Authors: Jiang, ZL Reay, D Kreppel, F Gambotto, A Feingold, E Kochanek, S McCarthy, SA Clemens, PR
Citation: Zl. Jiang et al., Local high-capacity adenovirus-mediated mCTLA4lg and mCD40lg expression prolongs recombinant gene expression in skeletal muscle, MOL THER, 3(6), 2001, pp. 892-900
Preexisting antiadenoviral immunity is not a barrier to efficient and stable transduction of the brain, mediated by novel high-capacity adenovirus vectors
Authors: Thomas, CE Schiedner, G Kochanek, S Castro, MG Lowenstein, PR
Citation: Ce. Thomas et al., Preexisting antiadenoviral immunity is not a barrier to efficient and stable transduction of the brain, mediated by novel high-capacity adenovirus vectors, HUM GENE TH, 12(7), 2001, pp. 839-846
Targeting of high-capacity adenoviral vectors
Authors: Biermann, V Volpers, C Hussmann, S Stock, A Kewes, H Schiedner, G Herrmann, A Kochanek, S
Citation: V. Biermann et al., Targeting of high-capacity adenoviral vectors, HUM GENE TH, 12(14), 2001, pp. 1757-1769
Comparison of long-term transgene expression after non-viral and adenoviral gene transfer into primary articular chondrocytes
Authors: Dinser, R Kreppel, F Zaucke, F Blank, C Paulsson, M Kochanek, S Maurer, P
Citation: R. Dinser et al., Comparison of long-term transgene expression after non-viral and adenoviral gene transfer into primary articular chondrocytes, HISTOCHEM C, 116(1), 2001, pp. 69-77
Toxicity associated with repeated administration of first-generation adenovirus vectors does not occur with a helper-dependent vector
Authors: O'Neal, VK Zhou, HS Morral, N Langston, C Parks, RJ Graham, FL Kochanek, S Beaudet, AL
Citation: Vk. O'Neal et al., Toxicity associated with repeated administration of first-generation adenovirus vectors does not occur with a helper-dependent vector, MOL MED, 6(3), 2000, pp. 179-195
Efficient transformation of primary human amniocytes by E1 functions of Ad5: Generation of new cell lines for adenoviral vector production
Authors: Schiedner, G Hertel, S Kochanek, S
Citation: G. Schiedner et al., Efficient transformation of primary human amniocytes by E1 functions of Ad5: Generation of new cell lines for adenoviral vector production, HUM GENE TH, 11(15), 2000, pp. 2105-2116
Peripheral infection with adenovirus causes unexpected long-term brain inflammation in animals injected intracranially with first-generation, but notwith high-capacity, adenovirus vectors: Toward realistic long-term neurological gene therapy for chronic diseases
Authors: Thomas, CE Schiedner, G Kochanek, S Castro, MG Lowenstein, PR
Citation: Ce. Thomas et al., Peripheral infection with adenovirus causes unexpected long-term brain inflammation in animals injected intracranially with first-generation, but notwith high-capacity, adenovirus vectors: Toward realistic long-term neurological gene therapy for chronic diseases, P NAS US, 97(13), 2000, pp. 7482-7487
DNA from both high-capacity and first-generation adenoviral vectors remains intact in skeletal muscle
Authors: Chen, HH Mack, LM Choi, SY Ontell, M Kochanek, S Clemens, PR
Citation: Hh. Chen et al., DNA from both high-capacity and first-generation adenoviral vectors remains intact in skeletal muscle, HUM GENE TH, 10(3), 1999, pp. 365-373
High-capacity adenoviral vectors for gene transfer and somatic gene therapy
Authors: Kochanek, S
Citation: S. Kochanek, High-capacity adenoviral vectors for gene transfer and somatic gene therapy, HUM GENE TH, 10(15), 1999, pp. 2451-2459
Use of a liver-specific promoter reduces immune response to the transgene in adenoviral vectors
Authors: Pastore, L Morral, N Zhou, HS Garcia, R Parks, RJ Kochanek, S Graham, FL Lee, B Beaudet, AL
Citation: L. Pastore et al., Use of a liver-specific promoter reduces immune response to the transgene in adenoviral vectors, HUM GENE TH, 10(11), 1999, pp. 1773-1781
Development of high-capacity adenoviral vectors for gene therapy
Authors: Kochanek, S
Citation: S. Kochanek, Development of high-capacity adenoviral vectors for gene therapy, THROMB HAEM, 82(2), 1999, pp. 547-551
Administration of helper-dependent adenoviral vectors and sequential delivery of different vector serotype for long-term liver-directed gene transferin baboons
Authors: Morral, N O'Neal, W Rice, K Leland, M Kaplan, J Piedra, PA Zhou, HS Parks, RJ Velji, R Aguilar-Cordova, E Wadsworth, S Graham, FL Kochanek, S Carey, KD Beaudet, AL
Citation: N. Morral et al., Administration of helper-dependent adenoviral vectors and sequential delivery of different vector serotype for long-term liver-directed gene transferin baboons, P NAS US, 96(22), 1999, pp. 12816-12821
Adenovirus-mediated regulable target gene expression in vivo
Authors: Burcin, MM Schiedner, G Kochanek, S Tsai, SY O'Malley, BW
Citation: Mm. Burcin et al., Adenovirus-mediated regulable target gene expression in vivo, P NAS US, 96(2), 1999, pp. 355-360
Frequency and stability of chromosomal integration of adenovirus vectors
Authors: Harui, A Suzuki, S Kochanek, S Mitani, K
Citation: A. Harui et al., Frequency and stability of chromosomal integration of adenovirus vectors, J VIROLOGY, 73(7), 1999, pp. 6141-6146
High doses of a helper-dependent adenoviral vector yield supraphysiological levels of alpha(1)-antitrypsin with negligible toxicity
Authors: Morral, N Parks, RJ Zhou, HS Langston, C Schiedner, G Quinones, J Graham, FL Kochanek, S Beaudet, AL
Citation: N. Morral et al., High doses of a helper-dependent adenoviral vector yield supraphysiological levels of alpha(1)-antitrypsin with negligible toxicity, HUM GENE TH, 9(18), 1998, pp. 2709-2716
Risultati: 1-15 |